Suppr超能文献

暴露于重金属化合物的人血小板表面促凝血活性增加。

Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds.

作者信息

Goodwin C A, Wheeler-Jones C P, Namiranian S, Bokkala S, Kakkar V V, Authi K S, Scully M F

机构信息

Thrombosis Research Institute, London, U.K.

出版信息

Biochem J. 1995 May 15;308 ( Pt 1)(Pt 1):15-21. doi: 10.1042/bj3080015.

Abstract

One of the essential roles for platelets in haemostasis is in the potentiation of blood clotting due to the contribution of anionic phospholipid from the surface of the cells, as an essential cofactor to the proteolytic reactions of coagulation (platelet procoagulant activity). Only a limited number of agonists are known to initiate platelet procoagulant activity. In this study the rate of thrombin formation on the platelet surface was observed to increase in a dose-dependent manner upon treatment of washed platelets with heavy-metal compounds. Unlike the immediate increase observed upon treatment of platelets with calcium ionophore, A23187, the change due to these agents was progressive, approaching a maximum after 10 min. The maximum-fold acceleration of the rate of thrombin formation compared with control platelets was calculated for HgCl2 (56-fold), AgNO3 (42-fold) phenylmercuriacetate (24-fold) and thimerosal (14-fold), compared with 70-fold observed for calcium ionophore. The increase in procoagulant activity due to HgCl2 coincided with a large increase in intracellular calcium and phosphorylation of 22 and 45 kDa proteins. It is considered that the mechanism responsible for the increase in procoagulant activity is exposure of anionic phospholipids. This was detected by a 2-fold increase in the binding of 125I-annexin V upon addition of HgCl2, compared with resting platelets (3-fold on treatment of platelets with calcium ionophore). In contrast to the generation of activity by A23187 and other known agonists of this reaction, heavy-metal compounds appeared to cause little or no release of microparticles from the platelet surface. Since HgCl2 did not cause aggregation of platelets or significant release of serotinin, these findings may give further support to the need for exposure and ligation of glycoprotein IIb:IIIa for vesiculization to occur. Treatment of platelets with heavy metals may constitute a new approach to investigating the early changes in the cell membrane which lead to increased expression of anionic phospholipid.

摘要

血小板在止血过程中的一个重要作用是通过细胞表面阴离子磷脂的作用来增强血液凝固,作为凝血蛋白水解反应的必需辅助因子(血小板促凝活性)。已知只有有限数量的激动剂能引发血小板促凝活性。在本研究中,用重金属化合物处理洗涤后的血小板后,观察到血小板表面凝血酶形成的速率呈剂量依赖性增加。与用钙离子载体A23187处理血小板后立即出现的增加不同,这些试剂引起的变化是渐进性的,10分钟后接近最大值。计算得出,与对照血小板相比,HgCl2(56倍)、AgNO3(42倍)、苯基汞乙酸盐(24倍)和硫柳汞(14倍)使凝血酶形成速率的最大加速倍数,而钙离子载体为70倍。HgCl2导致的促凝活性增加与细胞内钙的大量增加以及22 kDa和45 kDa蛋白质的磷酸化同时发生。据认为,促凝活性增加的机制是阴离子磷脂暴露。加入HgCl2后,与静息血小板相比,125I-膜联蛋白V的结合增加了2倍(用钙离子载体处理血小板时增加3倍),从而检测到了这一点。与A23187和该反应的其他已知激动剂产生活性不同,重金属化合物似乎很少或不会导致血小板表面微粒释放。由于HgCl2不会引起血小板聚集或5-羟色胺的显著释放,这些发现可能进一步支持了囊泡化发生需要糖蛋白IIb:IIIa暴露和连接的观点。用重金属处理血小板可能构成一种新的方法,用于研究导致阴离子磷脂表达增加的细胞膜早期变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb26/1136837/541797835a12/biochemj00063-0028-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验